Development and Validation of a Highly Sensitive and Rapid LC-MS

Zhengchao Ji, Tingting Li, Xin Zhao, Wei Ma, Yanyan Li, Jing Huang

Open access · goldAbstract read

In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it

0cells of the map it votes in

2citing papers in PubMed

0.3field-weighted citation impact, top 43% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

Modern Analytical Techniques in Epilepsy Research.International journal of molecular sciences · 2026
Review
Stratified Therapeutic Drug Monitoring Could Potentially Improve the Efficacy and Safety of Oxcarbazepine in Children with Epilepsy: Novel Insights from a Single-Center, Large-Sample, Retrospective Real-World Study.Pharmaceuticals (Basel, Switzerland) · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Zhengchao JiDepartment of Laboratory Medicine, The First Hospital of Jilin University, Jilin University, Changchun 130021, China.

Tingting LiVascular Surgery, General Surgery Center, The First Hospital of Jilin University, Jilin University, Changchun 130021, China.

Xin ZhaoDepartment of Health Examination Center, The First Hospital of Jilin University, Jilin University, Changchun 130021, China.

Wei MaDepartment of Pharmacy, The First Hospital of Jilin University, Jilin University, Changchun 130021, China.

Yanyan LiDepartment of Laboratory Medicine, The First Hospital of Jilin University, Jilin University, Changchun 130021, China.

Jing HuangDepartment of Laboratory Medicine, The First Hospital of Jilin University, Jilin University, Changchun 130021, China.

First Hospital of Jilin University · CNJilin University · CN

Funding

Department of Science and Technology of Jilin Province Grant number: 20210203068SFFinance Department of Jilin Province Grant Number: JLSWSRCZX221-056First Hospital of Jilin University Grant Number: JDYY2021-A0009Project of Jilin Provincial Department of science and technology Grant Number: 20200404167YY

6 · The paper itself

Abstract

A sensitive and rapid bioanalytical method based on the LC-triple-stage fragmentation (LC-MS

Indexed as

Drug MonitoringEpilepsyCarbamazepineChromatography, High Pressure LiquidChromatography, LiquidHumansOxcarbazepineReproducibility of ResultsTandem Mass SpectrometryCarbamazepineOxcarbazepine10-hydroxycarbazepineLC-MS3oxcarbazepinetherapeutic drug monitoringvalidation

Identifiers

PMID36080439

DOI10.3390/molecules27175670

PMCPMC9457704

OpenAlexW4295082521

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.